Crinetics Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Crinetics Pharmaceuticals, Inc. has filed 671 SEC EDGAR filings since 16 Nov 2015

SEC filing history

Showing 551-575 of 671 matching filings.

Per page
25
Current page
23
4

4 filing

Filing date
17 Apr 2020
Reporting date
15 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-233246

424B5

Filing date
15 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38583

8-K

Filing date
15 Apr 2020
Reporting date
14 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38583

FORM 8-K

Filing date
14 Apr 2020
Reporting date
14 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-233246

424B5

Filing date
14 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Apr 2020
Reporting date
03 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38583

FORM 8-K

Filing date
06 Apr 2020
Reporting date
06 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Mar 2020
Reporting date
20 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38583

8-K

Filing date
09 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90577

SC 13G filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90577

SC 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90577

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Feb 2020
Reporting date
07 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
11 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
11 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
11 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90577

SC 13G

Filing date
11 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90577

SC 13G/A filing

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Feb 2020
Reporting date
04 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90577

SC 13G/A

Filing date
06 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .